Literature DB >> 7060906

Metronidazole: an alternate therapy for antibiotic-associated colitis.

R D Cherry, D Portnoy, M Jabbari, D S Daly, D G Kinnear, C A Goresky.   

Abstract

The results of treatment of 13 consecutive cases of antibiotic-associated pseudomembranous colitis with oral metronidazole are described. The diagnosis was made by typical sigmoidoscopic appearance with a confirming characteristic colonic biopsy specimen and/or stools positive for Clostridium difficile cytotoxin. All patients responded with the disappearance of diarrhea between 1 and 5 days. Two patients experienced relapse when the therapy was discontinued. Our experience with metronidazole shows that it is an effective treatment for antibiotic-associated pseudomembranous colitis. The response to metronidazole treatment compares favorably with that usually obtained with vancomycin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7060906

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Comparative activity of metronidazole and tinidazole against Clostridium difficile and Peptostreptococcus anaerobius.

Authors:  A M Jokipii; L Jokipii
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

2.  Pseudomembranous colitis secondary to metronidazole.

Authors:  J J Daly; K V Chowdary
Journal:  Dig Dis Sci       Date:  1983-06       Impact factor: 3.199

3.  Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.

Authors:  T Peláez; L Alcalá; R Alonso; M Rodríguez-Créixems; J M García-Lechuz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

4.  Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile.

Authors:  R P Bolton; M A Culshaw
Journal:  Gut       Date:  1986-10       Impact factor: 23.059

Review 5.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

Review 6.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

7.  Nosocomial diarrhoeas in a surgical division hyperendemic for Clostridium difficile: epidemiologic aspects emerging from an analysis of clinical records.

Authors:  P Urbano; S Le Brun
Journal:  Eur J Epidemiol       Date:  1986-12       Impact factor: 8.082

8.  [Clostridium difficile and antibiotic-associated colitis in risk patients: 2-month epidemiologic study in an intensive care unit].

Authors:  K Loeschke; R Hauck; R Halbritter; P Pfaller; G Ruckdeschel
Journal:  Klin Wochenschr       Date:  1983-11-02

9.  Treatment of Clostridium difficile-associated disease with teicoplanin.

Authors:  F de Lalla; G Privitera; E Rinaldi; G Ortisi; D Santoro; G Rizzardini
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.